ポイントオブケア（POC）凝固検査の世界市場レポート 2024年

ポイントオブケア（POC）凝固検査市場は、心血管疾患（CVD）の罹患率の増加により成長が見込まれています。CVDには、冠動脈疾患や脳血管疾患など、心臓や血管に影響を及ぼすさまざまな疾患が含まれます。POC凝固検査は、凝固状態に関するリアルタイム情報を提供することでタイムリーな介入を可能にし、特に心臓手術後の出血性合併症のリスクを低減することで、CVD治療において重要な役割を果たしています。例えば、2023年5月、米国疾病予防管理センターは、2021年に米国で心臓病が約695,000人の命を奪い、死亡者数の5人に1人を占めると報告しました。最も多い冠動脈性心疾患は、2021年に375,476人が死亡しました。このような心血管疾患の有病率の増加は、POC凝固検査市場の成長を支える重要な要因です。

ポイントオブケア（POC）凝固検査市場の主要企業は、競争力を強化するために戦略的提携に注力しています。このような提携には、2つ以上の当事者間で、特定の相互に有益な目標に向けて取り組むという正式な契約が含まれます。例えば、2021年10月、トリビトロン・ヘルスケアはDiagon Ltd.およびVanguard Diagnosticsと提携し、凝固アナライザー製品を発表しました。これらの分析装置は正確で効率的な凝固検査を提供し、この提携は患者の診断と管理を強化することを目的としています。様々なヘルスケア環境に対応できるよう設計されており、凝固検査をより身近なものとします。

2023年12月、スイスの製薬会社ロシュはルミラデックス社を3億5,000万米ドルで買収しました。この買収によりロシュの診断薬ポートフォリオが強化され、ペイシェントジャーニー全体をカバーするポイント・オブ・ケアソリューションを通じて、より患者中心のヘルスケアが可能になります。英国を拠点とするルミラデックス社は、ポイントオブケアの凝固検査に特化しています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 マクロ経済シナリオ

• 高インフレが市場に与える影響
• ウクライナ・ロシア戦争が市場に与える影響
• COVID-19による市場への影響

第5章 世界の市場規模と成長

• 世界の市場促進要因と抑制要因
  • 市場促進要因
  • 市場抑制要因
• 世界の市場規模実績と成長、2018年～2023年
• 世界の市場規模予測と成長、2023年～2028年、2033年

第6章 市場セグメンテーション

• 世界のポイントオブケア（POC）凝固検査市場、技術別セグメンテーション、実績および予測、2018年～2023年、2023年～2028年、2033年
• 光学技術
• 機械技術
• 電気化学技術
• 世界のポイントオブケア（POC）凝固検査市場、流通チャネル別セグメンテーション、実績および予測、2018年～2023年、2023年～2028年、2033年
• 直接入札
• 小売り
• 世界のポイントオブケア（POC）凝固検査市場、エンドユーザー別セグメンテーション、実績および予測、2018年～2023年、2023年～2028年、2033年
• 病院
• クリニック
• 在宅ケア

第7章 地域別・国別分析

• 世界のポイントオブケア（POC）凝固検査市場、地域別、実績および予測、2018年～2023年、2023年～2028年、2033年
• 世界のポイントオブケア（POC）凝固検査市場、国別、実績および予測、2018年～2023年、2023年～2028年、2033年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• ポイントオブケア（POC）凝固検査市場の競合情勢
• ポイントオブケア（POC）凝固検査市場の企業プロファイル
  • AT&T Corporation
  • Siemens Healthcare GmbH
  • Thermo Fisher Scientific Inc.
  • Abbott Laboratories
  • F. Hoffmann-La Roche Ltd.

第31章 その他の大手企業と革新的企業

• Danaher Corporation
• Medtronic Plc
• Koninklijke Philips NV
• Sysmex Corporation
• IDEXX Laboratories Inc.
• Quidel Corporation
• Bio-Rad Laboratories Inc.
• Teleflex Incorporated
• Werfen SA
• Nihon Kohden Corporation
• Horiba Ltd.
• Hycel
• Nova Biomedical Corporation
• Haemonetics Corporation
• Maccura Biotechnology Co. Ltd.

第32章 競合ベンチマーキング

第33章 競合ダッシュボード

第34章 主要な合併と買収

第35章 将来の展望と潜在的分析

第36章 付録

Point-of-care (POC) coagulation testing is a diagnostic method that evaluates blood clotting function at or near the patient's location, rather than in a centralized lab. It provides rapid results, typically within minutes, enabling healthcare professionals to make timely treatment decisions and optimize anticoagulation therapy.

The main technologies used in POC coagulation testing are optical, mechanical, and electrochemical. Optical technology utilizes light for various applications, including data transfer, imaging, and sensing. These tests are distributed through channels such as direct tenders and retail to end-users such as hospitals, clinics, and home care settings.

The point-of-care (POC) coagulation testing market research report is one of a series of new reports from The Business Research Company that provides point-of-care (POC) coagulation testing market statistics, including point-of-care (POC) coagulation testing industry global market size, regional shares, competitors with a point-of-care (POC) coagulation testing market share, detailed point-of-care (POC) coagulation testing market segments, market trends and opportunities, and any further data you may need to thrive in the point-of-care (POC) coagulation testing industry. This point-of-care (POC) coagulation testing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The point-of-care (POC) coagulation testing market size has grown strongly in recent years. It will grow from $1.12 billion in 2023 to $1.18 billion in 2024 at a compound annual growth rate (CAGR) of 5.9%. The growth in the historic period can be attributed to several factors, including the rise in patient demand, the growing trend of point-of-care testing, the high reliability of coagulation status on PT tests, automation, and integration with electronic health records (EHRs), as well as the rising incidence of cardiovascular diseases and blood disorders.

The point-of-care (POC) coagulation testing market size is expected to see steady growth in the next few years. It will grow to $1.42 billion in 2028 at a compound annual growth rate (CAGR) of 4.6%. The forecasted growth is driven by expanding applications in healthcare, increasing demand in homecare settings, and the rising prevalence of chronic blood disorders. Patient demand for rapid and accurate testing, along with the increase in point-of-care testing, also contribute to this growth. Major trends in the forecast period include technological advancements, high demand in developed countries, expanding applications in healthcare, the impact of COVID-19, and the use of multiplexing in point-of-care diagnostics.

The point-of-care (POC) coagulation testing market is expected to grow due to the increasing incidence of cardiovascular diseases (CVDs). CVDs encompass a range of disorders affecting the heart and blood vessels, such as coronary heart disease and cerebrovascular disease. POC coagulation testing plays a crucial role in CVD treatment by providing real-time information on coagulation status, enabling timely interventions and reducing the risk of bleeding complications, particularly after cardiac surgery. For example, in May 2023, the Centers for Disease Control and Prevention reported that heart disease claimed about 695,000 lives in the United States in 2021, accounting for 1 in 5 deaths. Coronary heart disease, the most common type, caused 375,476 deaths in 2021. This increasing prevalence of cardiovascular diseases is a key driver behind the growth of the POC coagulation testing market.

Major companies in the point-of-care (POC) coagulation testing market are concentrating on strategic collaborations to enhance their competitive position. These collaborations involve formal agreements between two or more parties to work towards specific, mutually beneficial goals. For example, in October 2021, Trivitron Healthcare partnered with Diagon Ltd. and Vanguard Diagnostics to introduce Coagulation Analyzer products. These analyzers offer precise and efficient coagulation testing, with the collaboration aimed at enhancing patient diagnosis and management. The range of analyzers is designed to cater to various healthcare settings, making coagulation testing more accessible.

In December 2023, Roche, a Switzerland-based pharmaceutical company, acquired LumiraDx Ltd. for $350 million. This acquisition enhances Roche's diagnostics portfolio, enabling more patient-centric healthcare through point-of-care solutions that cover the entire patient journey. LumiraDx Ltd., based in the UK, specializes in point-of-care coagulation testing.

Major companies operating in the point-of-care (poc) coagulation testing market report are AT&T Corporation, Siemens Healthcare GmbH, Thermo Fisher Scientific Inc., Abbott Laboratories, F. Hoffmann-La Roche Ltd., Danaher Corporation, Medtronic Plc, Koninklijke Philips N.V., Sysmex Corporation, IDEXX Laboratories Inc., Quidel Corporation, Bio-Rad Laboratories Inc., Teleflex Incorporated, Werfen SA, Nihon Kohden Corporation, Horiba Ltd., Hycel, Nova Biomedical Corporation, Haemonetics Corporation, Maccura Biotechnology Co. Ltd., Helena Laboratories Corporation, Abaxis Inc., ARKRAY Inc., Radiometer Medical ApS, HemoSonics LLC, iLine Microsystems SL, Corgenix Medical Corporation, Quotient Limited, Micropoint Bioscience Inc., Beijing Succeeder Technology Inc., EKF Diagnostics Holdings plc

North America was the largest region in the point-of-care (POC) coagulation testing market in 2023. The regions covered in the point-of-care (poc) coagulation testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the point-of-care (poc) coagulation testing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The point-of-care (POC) coagulation testing market consists of revenues earned by entities by providing coagulation testing services, on-site hemostasis testing, point-of-care diagnostic services, and rapid coagulation analysis. The market value includes the value of related goods sold by the service provider or included within the service offering. The point-of-care (POC) coagulation testing market also includes sales of coagulation analyzers, test strips, prothrombin time (PT) monitors, D-dimer testing devices, and point-of-care coagulation testing kits. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Point-of-Care (POC) Coagulation Testing Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on point-of-care (POC) coagulation testing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
• Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
• Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
• Measure the impact of high global inflation on market growth.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for point-of-care (POC) coagulation testing? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The point-of-care (POC) coagulation testing market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of covid 19 on supply chains and consumption patterns.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

• 1) By Technology: Optical Technology; Mechanical Technology; Electrochemical Technology
• 2) By Distribution Channel: Direct Tenders; Retail
• 3) By End-User: Hospitals; Clinics; Home care
• Companies Mentioned: AT&T Corporation; Siemens Healthcare GmbH; Thermo Fisher Scientific Inc.; Abbott Laboratories; F. Hoffmann-La Roche Ltd.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Point-of-Care (POC) Coagulation Testing Market Characteristics

3. Point-of-Care (POC) Coagulation Testing Market Trends And Strategies

4. Point-of-Care (POC) Coagulation Testing Market - Macro Economic Scenario

• 4.1. Impact Of High Inflation On The Market
• 4.2. Ukraine-Russia War Impact On The Market
• 4.3. COVID-19 Impact On The Market

5. Global Point-of-Care (POC) Coagulation Testing Market Size and Growth

• 5.1. Global Point-of-Care (POC) Coagulation Testing Market Drivers and Restraints
  • 5.1.1. Drivers Of The Market
  • 5.1.2. Restraints Of The Market
• 5.2. Global Point-of-Care (POC) Coagulation Testing Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
• 5.3. Global Point-of-Care (POC) Coagulation Testing Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Point-of-Care (POC) Coagulation Testing Market Segmentation

• 6.1. Global Point-of-Care (POC) Coagulation Testing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Optical Technology
• Mechanical Technology
• Electrochemical Technology
• 6.2. Global Point-of-Care (POC) Coagulation Testing Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Direct Tenders
• Retail
• 6.3. Global Point-of-Care (POC) Coagulation Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Hospitals
• Clinics
• Home care

7. Point-of-Care (POC) Coagulation Testing Market Regional And Country Analysis

• 7.1. Global Point-of-Care (POC) Coagulation Testing Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 7.2. Global Point-of-Care (POC) Coagulation Testing Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Point-of-Care (POC) Coagulation Testing Market

• 8.1. Asia-Pacific Point-of-Care (POC) Coagulation Testing Market Overview
• Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Point-of-Care (POC) Coagulation Testing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.3. Asia-Pacific Point-of-Care (POC) Coagulation Testing Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.4. Asia-Pacific Point-of-Care (POC) Coagulation Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Point-of-Care (POC) Coagulation Testing Market

• 9.1. China Point-of-Care (POC) Coagulation Testing Market Overview
• 9.2. China Point-of-Care (POC) Coagulation Testing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.3. China Point-of-Care (POC) Coagulation Testing Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.4. China Point-of-Care (POC) Coagulation Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Point-of-Care (POC) Coagulation Testing Market

• 10.1. India Point-of-Care (POC) Coagulation Testing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.2. India Point-of-Care (POC) Coagulation Testing Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.3. India Point-of-Care (POC) Coagulation Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Point-of-Care (POC) Coagulation Testing Market

• 11.1. Japan Point-of-Care (POC) Coagulation Testing Market Overview
• 11.2. Japan Point-of-Care (POC) Coagulation Testing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.3. Japan Point-of-Care (POC) Coagulation Testing Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.4. Japan Point-of-Care (POC) Coagulation Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Point-of-Care (POC) Coagulation Testing Market

• 12.1. Australia Point-of-Care (POC) Coagulation Testing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.2. Australia Point-of-Care (POC) Coagulation Testing Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.3. Australia Point-of-Care (POC) Coagulation Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Point-of-Care (POC) Coagulation Testing Market

• 13.1. Indonesia Point-of-Care (POC) Coagulation Testing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.2. Indonesia Point-of-Care (POC) Coagulation Testing Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.3. Indonesia Point-of-Care (POC) Coagulation Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Point-of-Care (POC) Coagulation Testing Market

• 14.1. South Korea Point-of-Care (POC) Coagulation Testing Market Overview
• 14.2. South Korea Point-of-Care (POC) Coagulation Testing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.3. South Korea Point-of-Care (POC) Coagulation Testing Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.4. South Korea Point-of-Care (POC) Coagulation Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Point-of-Care (POC) Coagulation Testing Market

• 15.1. Western Europe Point-of-Care (POC) Coagulation Testing Market Overview
• 15.2. Western Europe Point-of-Care (POC) Coagulation Testing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.3. Western Europe Point-of-Care (POC) Coagulation Testing Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.4. Western Europe Point-of-Care (POC) Coagulation Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Point-of-Care (POC) Coagulation Testing Market

• 16.1. UK Point-of-Care (POC) Coagulation Testing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.2. UK Point-of-Care (POC) Coagulation Testing Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.3. UK Point-of-Care (POC) Coagulation Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Point-of-Care (POC) Coagulation Testing Market

• 17.1. Germany Point-of-Care (POC) Coagulation Testing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.2. Germany Point-of-Care (POC) Coagulation Testing Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.3. Germany Point-of-Care (POC) Coagulation Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Point-of-Care (POC) Coagulation Testing Market

• 18.1. France Point-of-Care (POC) Coagulation Testing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.2. France Point-of-Care (POC) Coagulation Testing Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.3. France Point-of-Care (POC) Coagulation Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Point-of-Care (POC) Coagulation Testing Market

• 19.1. Italy Point-of-Care (POC) Coagulation Testing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.2. Italy Point-of-Care (POC) Coagulation Testing Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.3. Italy Point-of-Care (POC) Coagulation Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Point-of-Care (POC) Coagulation Testing Market

• 20.1. Spain Point-of-Care (POC) Coagulation Testing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.2. Spain Point-of-Care (POC) Coagulation Testing Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.3. Spain Point-of-Care (POC) Coagulation Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Point-of-Care (POC) Coagulation Testing Market

• 21.1. Eastern Europe Point-of-Care (POC) Coagulation Testing Market Overview
• 21.2. Eastern Europe Point-of-Care (POC) Coagulation Testing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.3. Eastern Europe Point-of-Care (POC) Coagulation Testing Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.4. Eastern Europe Point-of-Care (POC) Coagulation Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Point-of-Care (POC) Coagulation Testing Market

• 22.1. Russia Point-of-Care (POC) Coagulation Testing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.2. Russia Point-of-Care (POC) Coagulation Testing Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.3. Russia Point-of-Care (POC) Coagulation Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Point-of-Care (POC) Coagulation Testing Market

• 23.1. North America Point-of-Care (POC) Coagulation Testing Market Overview
• 23.2. North America Point-of-Care (POC) Coagulation Testing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.3. North America Point-of-Care (POC) Coagulation Testing Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.4. North America Point-of-Care (POC) Coagulation Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Point-of-Care (POC) Coagulation Testing Market

• 24.1. USA Point-of-Care (POC) Coagulation Testing Market Overview
• 24.2. USA Point-of-Care (POC) Coagulation Testing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.3. USA Point-of-Care (POC) Coagulation Testing Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.4. USA Point-of-Care (POC) Coagulation Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Point-of-Care (POC) Coagulation Testing Market

• 25.1. Canada Point-of-Care (POC) Coagulation Testing Market Overview
• 25.2. Canada Point-of-Care (POC) Coagulation Testing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.3. Canada Point-of-Care (POC) Coagulation Testing Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.4. Canada Point-of-Care (POC) Coagulation Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Point-of-Care (POC) Coagulation Testing Market

• 26.1. South America Point-of-Care (POC) Coagulation Testing Market Overview
• 26.2. South America Point-of-Care (POC) Coagulation Testing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.3. South America Point-of-Care (POC) Coagulation Testing Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.4. South America Point-of-Care (POC) Coagulation Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Point-of-Care (POC) Coagulation Testing Market

• 27.1. Brazil Point-of-Care (POC) Coagulation Testing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.2. Brazil Point-of-Care (POC) Coagulation Testing Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.3. Brazil Point-of-Care (POC) Coagulation Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Point-of-Care (POC) Coagulation Testing Market

• 28.1. Middle East Point-of-Care (POC) Coagulation Testing Market Overview
• 28.2. Middle East Point-of-Care (POC) Coagulation Testing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.3. Middle East Point-of-Care (POC) Coagulation Testing Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.4. Middle East Point-of-Care (POC) Coagulation Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Point-of-Care (POC) Coagulation Testing Market

• 29.1. Africa Point-of-Care (POC) Coagulation Testing Market Overview
• 29.2. Africa Point-of-Care (POC) Coagulation Testing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.3. Africa Point-of-Care (POC) Coagulation Testing Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.4. Africa Point-of-Care (POC) Coagulation Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Point-of-Care (POC) Coagulation Testing Market Competitive Landscape And Company Profiles

• 30.1. Point-of-Care (POC) Coagulation Testing Market Competitive Landscape
• 30.2. Point-of-Care (POC) Coagulation Testing Market Company Profiles
  • 30.2.1. AT&T Corporation
    • 30.2.1.1. Overview
    • 30.2.1.2. Products and Services
    • 30.2.1.3. Strategy
    • 30.2.1.4. Financial Performance
  • 30.2.2. Siemens Healthcare GmbH
    • 30.2.2.1. Overview
    • 30.2.2.2. Products and Services
    • 30.2.2.3. Strategy
    • 30.2.2.4. Financial Performance
  • 30.2.3. Thermo Fisher Scientific Inc.
    • 30.2.3.1. Overview
    • 30.2.3.2. Products and Services
    • 30.2.3.3. Strategy
    • 30.2.3.4. Financial Performance
  • 30.2.4. Abbott Laboratories
    • 30.2.4.1. Overview
    • 30.2.4.2. Products and Services
    • 30.2.4.3. Strategy
    • 30.2.4.4. Financial Performance
  • 30.2.5. F. Hoffmann-La Roche Ltd.
    • 30.2.5.1. Overview
    • 30.2.5.2. Products and Services
    • 30.2.5.3. Strategy
    • 30.2.5.4. Financial Performance

31. Point-of-Care (POC) Coagulation Testing Market Other Major And Innovative Companies

• 31.1. Danaher Corporation
• 31.2. Medtronic Plc
• 31.3. Koninklijke Philips N.V.
• 31.4. Sysmex Corporation
• 31.5. IDEXX Laboratories Inc.
• 31.6. Quidel Corporation
• 31.7. Bio-Rad Laboratories Inc.
• 31.8. Teleflex Incorporated
• 31.9. Werfen SA
• 31.10. Nihon Kohden Corporation
• 31.11. Horiba Ltd.
• 31.12. Hycel
• 31.13. Nova Biomedical Corporation
• 31.14. Haemonetics Corporation
• 31.15. Maccura Biotechnology Co. Ltd.

32. Global Point-of-Care (POC) Coagulation Testing Market Competitive Benchmarking

33. Global Point-of-Care (POC) Coagulation Testing Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Point-of-Care (POC) Coagulation Testing Market

35. Point-of-Care (POC) Coagulation Testing Market Future Outlook and Potential Analysis

• 35.1 Point-of-Care (POC) Coagulation Testing Market In 2028 - Countries Offering Most New Opportunities
• 35.2 Point-of-Care (POC) Coagulation Testing Market In 2028 - Segments Offering Most New Opportunities
• 35.3 Point-of-Care (POC) Coagulation Testing Market In 2028 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer